Chengdu Easton Biopharmaceuticals Co., Ltd. (SHA:688513)
51.16
+0.80 (1.59%)
Sep 30, 2026, 3:00 PM CST
| Market Cap | 8.88B -3.6% |
| Revenue (ttm) | 1.34B +0.1% |
| Net Income | 277.24M +21.4% |
| EPS | 1.60 +23.1% |
| Shares Out | 173.57M |
| PE Ratio | 31.97 |
| Forward PE | 31.39 |
| Dividend | 0.49 (0.96%) |
| Ex-Dividend Date | Jun 2, 2026 |
| Volume | 2,320,174 |
| Open | 50.80 |
| Previous Close | 50.36 |
| Day's Range | 50.37 - 52.50 |
| 52-Week Range | 40.25 - 80.48 |
| Beta | 0.00 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 28, 2026 |